logo-loader
AIM:BELL

Belluscura PLC

Receive alerts
Market:
AIM
Price
19.70 GBX
Day Change
1.03%
Market Cap:
£32.38 m
52 weeks high
52.00
52 weeks low
17.00

In brief

Belluscura PLC is a leading medical device developer focused on lightweight and portable oxygen enrichment technology.

The company either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura's first product, the X-PLO₂R, is a lightweight FDA cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices.